top of page
PHARMXHEALTHONE
TERMS AND CONDITIONS OF WEBSITE USE, HEALTHCARE SERVICES, TELEHEALTH, PAYMENTS, COMMUNICATIONS, AND RELATED SERVICES
Effective Date: January 1, 2024
Last Updated: October 6, 2026
Legal Entity: PHARM X UNIVERSAL, LLC d/b/a PHARMXHEALTHONE
Business Name: PharmXHealthOne (“PHO”)
Primary Clinic Location: 2828 South Seacrest Boulevard, Suite 216, Boynton Beach, Florida 33435
Telephone: 561-778-8121
Email: health@pharmxhealthone.com
These Terms and Conditions (“Terms”) govern access to and use of PharmXHealthOne’s website, public forms, digital services, administrative services, cash-pay healthcare services, telehealth services, in-person services, clinical consultations, laboratory coordination, patient-specific medication and product ordering, community and church outreach programs, electronic communications, payments, and other services provided, arranged, or coordinated by PHO. These Terms are intended to explain the general rules governing the relationship between PHO and individuals who use PHO’s website, communicate with PHO, participate in PHO programs, obtain healthcare services from PHO, purchase or authorize patient-specific products or treatments, or otherwise interact with PHO.
1. ACCEPTANCE AND SCOPE OF THESE TERMS
By accessing or using the PHO website, submitting information through a PHO public form, scheduling or receiving an applicable PHO service, participating in a PHO program, communicating with PHO, authorizing a payment, or otherwise using a PHO service to which these Terms apply, you agree to comply with these Terms to the extent permitted by applicable law. These Terms establish PHO’s general administrative, business, website, communications, financial, and service rules, but they do not replace individualized clinical judgment, treatment-specific informed consent, a patient-specific treatment plan, PHO’s HIPAA Notice of Privacy Practices, PHO’s Legal Notice, Privacy Policy & Cookie Notice, telehealth consent, Good Faith Estimates, financial responsibility agreements, medication-specific disclosures, pharmacy information, laboratory documentation, or another agreement that applies to a particular service. If a mandatory legal requirement or a more specific properly executed agreement governing a particular service conflicts with these general Terms, the mandatory legal requirement or the more specific agreement controls that subject.
2. PHO’S LEGAL AND OPERATING STRUCTURE
PharmXHealthOne is operated by PHARM X UNIVERSAL, LLC d/b/a PHARMXHEALTHONE. PHO operates as an outpatient healthcare business and provides or coordinates healthcare services through appropriately licensed, registered, certified, or otherwise legally authorized healthcare professionals. References in these Terms to “PHO,” “PharmXHealthOne,” “we,” “us,” or “our” refer to the business entity unless the context specifically identifies an individual healthcare professional, pharmacy, laboratory, supplier, payment processor, or other independent third party. The fact that a person works for, contracts with, or assists PHO does not automatically mean that person is a physician or independently licensed healthcare professional. Clinical functions may be performed only by persons who are legally authorized to perform those functions within the limits of their respective professional authority.
3. REGULATORY AND LEGAL COMPLIANCE FRAMEWORK
PHO operates subject to applicable federal, Florida, and local healthcare, privacy, security, professional, consumer-protection, electronic-commerce, communications, pharmacy, laboratory, employment, business, and facility requirements. Depending upon the activity involved, these requirements may include HIPAA, the HITECH Act, 45 C.F.R. Parts 160 and 164, applicable requirements concerning substance-use-disorder information under 42 C.F.R. Part 2, Florida healthcare-professional licensing statutes and professional-board rules, Florida Statutes § 456.057 governing patient records, Florida Statutes § 456.47 governing telehealth, the Florida Health Care Clinic Act where applicable, applicable requirements administered by the Florida Agency for Health Care Administration (“AHCA”), applicable provisions of Chapter 408 of the Florida Statutes, Florida privacy and data-security laws, the federal No Surprises Act and Good Faith Estimate requirements, applicable FDA and pharmacy requirements, controlled-substance requirements, laboratory requirements, applicable Federal Trade Commission rules, the Telephone Consumer Protection Act and Federal Communications Commission requirements, Florida electronic-transaction law, and applicable Palm Beach County and City of Boynton Beach business, zoning, occupancy, safety, fire, and related local requirements. These Terms do not represent that every identified law applies to every PHO activity; rather, PHO applies the requirements that govern the particular service, provider, transaction, communication, facility, or business activity involved.
4. AHCA AND FLORIDA HEALTH CARE CLINIC REQUIREMENTS
PHO evaluates its organizational structure, ownership, service model, professional relationships, billing practices, and other operations under Florida health care clinic requirements, including the Florida Health Care Clinic Act, Chapter 400, Part X, Florida Statutes, and applicable AHCA requirements where those laws apply. Florida law distinguishes between healthcare entities that require clinic licensure and entities that fall within statutory exclusions or exemptions, and the applicable status depends on the facts and structure of the particular operation. PHO will maintain any license, exemption, registration, inspection requirement, posting, personnel documentation, or other regulatory control that applies to its actual operations. Nothing in these Terms should be interpreted as stating that PHO holds a particular AHCA license, certificate of exemption, or other AHCA designation unless that status has been independently verified and remains current. Florida’s Health Care Clinic Act establishes the state framework for clinic regulation and AHCA oversight, while the statutory definition of “clinic” also contains exclusions and exemptions. Online Sunshine
5. FLORIDA DEPARTMENT OF HEALTH, PROFESSIONAL LICENSURE, AND SCOPE OF PRACTICE
Healthcare professionals providing services through PHO are responsible for maintaining any license, registration, certification, prescribing authority, continuing-education requirement, professional-board compliance, supervision or collaboration requirement, and other credential required for their role. Each healthcare professional must practice within the scope of practice authorized by applicable Florida law and the rules governing that profession. Administrative staff, community outreach personnel, volunteers, and other non-clinical personnel do not acquire authority to diagnose a condition, prescribe medication, establish a medical treatment plan, or provide professional healthcare merely because they work with PHO. Where professional judgment is required, the appropriately licensed healthcare professional remains responsible for that judgment.
6. PHO IS A CASH-PAY HEALTHCARE PRACTICE
PHO operates on a cash-pay basis for PHO services. PHO does not accept or bill Medicare, Medicaid, or commercial health insurance for PHO’s own consultations, treatments, procedures, assessments, patient-specific products, or other PHO services. Patients and clients are responsible for payment of the PHO charges associated with services they authorize. A service being medical in nature does not mean that PHO will submit the charge to an insurance company or government payer, and a patient should not assume that a PHO service will be reimbursed by an insurance plan. If PHO ever changes this business model for a particular service, that change must be expressly communicated in writing and should not be inferred from the fact that PHO coordinates care with a laboratory, pharmacy, provider, or other healthcare entity that independently accepts insurance.
7. QUEST DIAGNOSTICS, LABCORP, AND THIRD-PARTY LABORATORY INSURANCE
PHO may order or coordinate laboratory testing through independent third-party laboratories, including Quest Diagnostics and Labcorp. These laboratories are separate healthcare entities with their own billing systems, insurance contracts, network participation, financial policies, privacy practices, and legal responsibilities. A patient may be able to use their health insurance directly with Quest Diagnostics or Labcorp for eligible laboratory testing, depending on the patient’s health plan, the laboratory’s network status, coverage requirements, medical-necessity rules, deductible, copayment, coinsurance, prior-authorization requirements, diagnosis coding, and other payer conditions. The ability to use insurance with one of these laboratories does not mean that PHO accepts, participates with, or bills that insurance plan. PHO does not guarantee that a laboratory test will be covered, that the laboratory is in network, that a payer will find the test medically necessary, or that a patient will owe no laboratory charges. Patients who wish to verify laboratory insurance coverage are responsible for contacting their health plan or the applicable laboratory.
8. GOOD FAITH ESTIMATES AND SELF-PAY PATIENT RIGHTS
Because PHO is a cash-pay practice, applicable federal Good Faith Estimate protections for uninsured and self-pay individuals are an important part of PHO’s financial process. When required by federal law, PHO will provide an estimate of reasonably expected charges for scheduled healthcare services or upon a qualifying request. A Good Faith Estimate reflects information reasonably available when the estimate is prepared and does not guarantee that unforeseen or additional medically necessary services will never be required. Federal rules also provide a patient-provider dispute-resolution process in qualifying circumstances when an eligible patient’s billed charges are at least $400 higher than the applicable Good Faith Estimate. Centers for Medicare & Medicaid Services PHO should maintain a separate public Good Faith Estimate / No Surprises Act notice in addition to this Terms page.
9. WEBSITE INFORMATION IS NOT INDIVIDUALIZED MEDICAL ADVICE
The PHO website may contain information concerning health conditions, weight management, hormone-related services, medications, peptides, NAD-related services, laboratory testing, body-composition assessment, aesthetics, body-contouring services, wellness services, procedures, technologies, or other healthcare subjects. Such information is provided for general educational and informational purposes and is not an individualized diagnosis, prescription, treatment recommendation, or substitute for professional medical evaluation. Website information cannot determine whether a particular medication or service is safe or appropriate for a specific person and should not be used as the sole basis for beginning, discontinuing, increasing, decreasing, or otherwise changing prescribed treatment.
10. NO PROVIDER-PATIENT RELATIONSHIP FROM WEBSITE OR EVENT USE
A provider-patient relationship is not created merely because an individual visits PHO’s website, calls PHO, sends a general email, completes a public contact form, fills out an Interest Card, registers for a PHO event, attends a church or community presentation, receives general educational information, communicates with community outreach personnel, or asks about a PHO service. A clinical relationship is established only through PHO’s approved clinical process and the involvement of an appropriately licensed healthcare professional. Providing contact information, paying an administrative or consultation fee, or asking for a specific treatment does not obligate a PHO healthcare professional to diagnose a condition, prescribe a medication, recommend a requested therapy, or accept the person for a particular treatment.
11. PATIENT ELIGIBILITY AND CLINICAL ACCEPTANCE
Not every individual is eligible for every PHO service, medication, procedure, or treatment. Eligibility may depend on medical history, current symptoms, current medications, allergies, laboratory results, contraindications, pregnancy status where relevant, age, health goals, prior treatment, provider judgment, state of residence, provider licensure, pharmacy restrictions, applicable federal or state law, and other clinically relevant circumstances. A provider may decline, delay, modify, or discontinue a requested treatment when the provider determines that it is clinically inappropriate, unsafe, unsupported by available information, outside the provider’s lawful authority, unavailable, or otherwise unsuitable for the patient. A patient’s preference for a particular product does not override provider judgment or applicable law.
12. ACCURACY AND COMPLETENESS OF PATIENT INFORMATION
Patients are responsible for providing accurate and reasonably complete information to PHO. PHO and its healthcare professionals may rely on patient-provided information when determining appropriate next steps, and incomplete or materially inaccurate information may create patient-safety risks. Patients should disclose relevant medical history, current prescription medications, over-the-counter medications, supplements, allergies, prior adverse reactions, relevant diagnoses, pregnancy status where applicable, recent procedures, laboratory information, other treating professionals, and significant changes in health when requested. PHO may delay, decline, modify, or discontinue non-emergency services when materially inaccurate or incomplete information prevents safe or lawful treatment.
13. IDENTIFICATION AND ADMINISTRATIVE REGISTRATION REQUIREMENTS
PHO may require appropriate identification and administrative documentation as part of registration and patient onboarding. Depending on the circumstances, PHO may request a driver’s license, passport, another accepted government-issued identification document, current contact information, completed new-patient registration information, a current medication list, recent laboratory results where available, and an insurance card when needed solely for outside laboratory coordination. The request for an insurance card to facilitate laboratory services does not mean that PHO accepts the patient’s insurance for PHO services. PHO may also require information reasonably necessary to verify identity, prevent fraud, protect patient records, or comply with healthcare and privacy laws.
14. INITIAL IN-PERSON PHO ASSESSMENT PROCESS
Where PHO’s care pathway calls for an initial in-person assessment before the provider consultation, that visit may include verification of identity and registration information, collection or review of required documents, review of the patient’s medication list, discussion of general health concerns and health goals, SECA mBCA assessment where appropriate, explanation of selected body-composition findings, review of available laboratory information, determination of whether additional testing is needed, issuance of laboratory orders by an authorized professional where appropriate, collection of applicable consultation fees, and scheduling of the subsequent healthcare-provider consultation. This preliminary process is designed to gather information necessary for safe and informed clinical evaluation and is not itself a guarantee that a particular treatment will be recommended.
15. MEDICAL-PROVIDER CONSULTATION AND TREATMENT PLANNING
The healthcare-provider consultation is the clinical evaluation during which the appropriately licensed professional considers the patient’s history, concerns, goals, available laboratory results, current medications, relevant physical or body-composition information, contraindications, treatment risks, alternatives, and other clinically relevant information. The provider may request additional testing, obtain additional medical records, recommend an in-person examination, request specialty consultation, recommend treatment, decline a requested treatment, modify a treatment concept, refer the patient to another professional, or determine that no PHO treatment is appropriate. The patient remains free to accept or decline a recommended treatment plan, and PHO does not guarantee that a requested medication or procedure will be approved.
16. PATIENT-SPECIFIC MEDICATION AND PRODUCT ORDERING
PHO does not maintain a general standing inventory of unassigned patient medications for anticipated future sale. Where medication, compounded therapy, or another patient-specific product is appropriate, PHO’s model is to order that item for the specific patient after completion of the applicable assessment, provider review, clinical determination, patient authorization, and payment process. The process may include evaluation of the patient’s health concerns and goals, laboratory review where clinically indicated, SECA mBCA assessment where relevant, provider consultation, treatment recommendation, informed consent, payment, submission of the patient-specific order, and pharmacy or supplier fulfillment. Payment does not compel a provider to authorize a clinically inappropriate treatment, and no product description, service menu, or published price guarantees that a medication will be prescribed.
17. PHARMACY, COMPOUNDING FACILITY, AND SUPPLIER RESPONSIBILITIES
PHO may coordinate patient-specific products with independent pharmacies, compounding pharmacies, FDA-registered outsourcing facilities, or other medical suppliers where appropriate. These entities remain responsible for their own licensure, registration, compounding authority, dispensing practices, labeling, storage, shipping, quality systems, sterility procedures, recall obligations, adverse-event reporting requirements where applicable, and other legal duties. PHO’s use of a particular pharmacy or supplier does not convert that independent entity into PHO or make PHO responsible for every independent action of the pharmacy or supplier. PHO nevertheless expects to maintain sufficient supplier information and traceability to support patient safety, clinical oversight, and appropriate response to recalls or product concerns.
18. COMPOUNDED MEDICATIONS
Certain PHO treatment plans may involve compounded medications when clinically appropriate and lawfully available. Compounded drugs are not FDA-approved in the same manner as approved manufactured drug products, meaning FDA does not review each compounded product for safety, effectiveness, and quality before marketing. FDA also distinguishes between compounding under section 503A of the Federal Food, Drug, and Cosmetic Act, which generally involves valid patient-specific prescriptions, and section 503B outsourcing facilities, which are subject to additional federal requirements. U.S. Food and Drug Administration PHO will not represent a compounded medication as FDA-approved and will not represent that compounded therapy is appropriate for every patient. The treating provider determines whether such therapy is clinically appropriate, subject to applicable law and appropriate informed consent.
19. OFF-LABEL PRESCRIBING
A licensed healthcare professional may, when lawful and clinically appropriate, prescribe an FDA-approved medication for a use, dosage, route, population, or other condition that differs from the medication’s approved labeling. Such use is commonly referred to as off-label prescribing. Off-label use does not mean that the medication itself is necessarily unapproved; rather, the specific use differs from the approved labeling. The treating professional remains responsible for determining whether the off-label use is appropriate for the individual patient based on professional judgment, available evidence, the patient’s circumstances, applicable law, risks and benefits, and informed consent where appropriate. General PHO website content does not constitute an individualized off-label recommendation.
20. CONTROLLED AND OTHERWISE RESTRICTED MEDICATIONS
When a requested or recommended treatment involves a controlled substance or another specially regulated medication, PHO and the treating healthcare professional must comply with applicable federal and state prescribing requirements, DEA rules where applicable, Florida law, telehealth restrictions, prescription-monitoring requirements, professional-board standards, and pharmacy requirements. The availability of telehealth or a PHO service does not guarantee that a controlled or restricted medication may legally or clinically be prescribed through that encounter.
21. MEDICATION SHIPPING, DELIVERY, RECEIPT, AND STORAGE
When a pharmacy or supplier ships a patient-specific medication or temperature-sensitive product directly to a patient, the patient is responsible for providing an accurate delivery address, monitoring delivery when appropriate, retrieving the shipment promptly, reviewing the package for obvious damage, following pharmacy or manufacturer storage instructions, and promptly contacting the dispensing pharmacy or PHO if the shipment appears damaged, improperly stored, lost, delayed, opened, altered, expired, or otherwise questionable. Patients should not use a medication that appears contaminated, damaged, expired, improperly stored, or inconsistent with the prescription or pharmacy instructions. Shipping delays, carrier failures, weather, or other delivery issues may involve the independent pharmacy, supplier, or carrier, and the appropriate resolution will depend upon the circumstances and applicable pharmacy or supplier policy.
22. RECALLS AND PRODUCT SAFETY NOTICES
If PHO receives reliable information concerning a medication or product recall, safety alert, contamination issue, labeling error, or other material product-safety concern affecting PHO patients, PHO may contact affected patients and coordinate with the applicable pharmacy, supplier, treating provider, or regulatory authority as appropriate. Patients should follow instructions issued by the dispensing pharmacy, treating provider, manufacturer, FDA, or other responsible authority and should not continue using a recalled or potentially unsafe product contrary to professional instructions.
23. TELEHEALTH SERVICES
PHO may provide telehealth services when clinically appropriate and legally authorized. The patient must accurately disclose the state and physical location from which the patient is participating at the time of the telehealth encounter because the treating professional’s authority to provide care generally depends on where the patient is physically located. For Florida encounters, Florida Statutes § 456.47 requires a telehealth provider to practice within the provider’s scope of practice and according to the prevailing professional standard applicable to in-person care, and it imposes particular rules on prescribing through telehealth. Online Sunshine A provider may determine that telehealth is insufficient and may require an in-person examination, diagnostic testing, laboratory testing, outside records, referral, or emergency evaluation before making a clinical decision.
24. TELEHEALTH TECHNOLOGY LIMITATIONS
Telehealth depends on telecommunications systems and may be affected by internet outages, device failures, interruptions, audio or video limitations, incomplete visual information, data-transmission delays, privacy limitations, inability to conduct portions of a physical examination, or other technological constraints. If a provider determines that the available technology or information is inadequate to provide safe care, the provider may suspend or end the remote encounter and recommend an alternative method of evaluation. Patients are responsible for participating from an environment that reasonably allows them to communicate and, where possible, protect their own privacy.
25. IN-PERSON SERVICES AND TREATMENTS
PHO may provide in-person consultations, assessments, procedures, treatment-related services, specimen collection, body-composition assessment, and other services within the lawful scope of its providers and staff. In-person care may require additional consent, examination, laboratory testing, pre-treatment instructions, aftercare instructions, follow-up, or referral depending upon the service. Patients must comply with reasonable safety, infection-control, clinical, and facility instructions given for the service. PHO may postpone or decline a non-emergency procedure when the patient’s condition, incomplete information, failure to follow preparation instructions, safety concerns, or provider judgment makes proceeding inappropriate.
26. TREATMENT-SPECIFIC SERVICES
PHO offers or may offer categories of services including weight-management care, hormone-related care, peptide-related therapies, NAD-related services, aesthetic services, body-contouring services, shockwave-related services, SECA mBCA assessment, wellness services, and other treatments or technologies. Each service category may have different eligibility requirements, contraindications, risks, expected benefits, treatment duration, follow-up requirements, laboratory requirements, informed-consent requirements, and pricing. General Terms cannot substitute for those service-specific clinical disclosures. The treating professional and applicable informed-consent documents govern the clinical details of a particular treatment.
27. MEDICAL EMERGENCIES
PHO is an outpatient practice and does not operate an emergency department, ambulance service, or after-hours/on-call emergency medical service. The PHO website, public forms, general email, public SMS program, website chat, social media, Interest Cards, community outreach channels, and ordinary administrative telephone communications must not be used as substitutes for emergency medical care. If an individual believes that a medical emergency is occurring, the individual should call 911 or seek immediate emergency medical care.
28. LABORATORY ORDERS AND RESULTS
A healthcare professional may determine that laboratory testing is needed before initiating a treatment, while treatment is ongoing, or as part of follow-up. Laboratory requirements may vary according to medical history, current medications, treatment category, recent results, safety considerations, and professional judgment. PHO may consider laboratory results previously obtained elsewhere when clinically appropriate, but a provider may require new or additional testing. Laboratory values must be interpreted in clinical context; a value outside a reference range does not by itself establish a diagnosis, and a value within a reference range does not necessarily exclude a medical condition.
29. ELATION HEALTH AND THE CLINICAL MEDICAL RECORD
PHO uses Elation Health as its approved electronic health record environment for detailed clinical information. Medical history, diagnoses, allergies, medications, laboratory results, provider assessments, treatment plans, clinical notes, informed-consent information, and other patient-care information should be maintained in the approved clinical record where appropriate. PHO administrative or operational systems should not be used as substitutes for the clinical record merely because they permit text entry or data storage.
30. QCOMMAND CENTER, AIRTABLE, AND OTHER OPERATIONAL SYSTEMS
PHO may use QCommand Center, Airtable, PHO Team Portal functions, forms, dashboards, reporting systems, and related databases for administrative and operational purposes. These systems may track matters such as lead status, appointment status, workflow ownership, event participation, operational requests, approvals, next administrative steps, reporting, and accountability. Unless a particular field or system has been specifically approved for the relevant protected clinical information, personnel should not place unnecessary diagnoses, detailed laboratory values, prescription details, treatment plans, or other sensitive clinical narrative in operational free-text fields. The existence of a technical capability to store information does not itself authorize that information to be placed there.
31. HIPAA AND PHO’S NOTICE OF PRIVACY PRACTICES
Where PHO is acting as a HIPAA-covered healthcare provider and information constitutes Protected Health Information, PHO handles that information according to applicable HIPAA Privacy, Security, and Breach Notification requirements. PHO maintains a separate HIPAA Notice of Privacy Practices explaining patient rights and PHO’s permitted uses and disclosures of PHI. HHS requires covered providers to maintain such a notice, make it available on request, and prominently post it on a website that describes services or benefits; HHS’s revised 2026 materials also address Part 2-related requirements. HHS.gov These Terms do not replace that Notice.
32. FLORIDA PATIENT RECORDS AND CONFIDENTIALITY
PHO and its healthcare professionals handle patient records according to applicable federal and Florida law. Florida Statutes § 456.057 addresses ownership and control of patient records, confidentiality, disclosure, and the furnishing of records or copies. PHO may require reasonable identity verification, authorization, or documentation establishing legal representative authority before releasing records. A request for records will be evaluated under the legal requirements applicable to the record and requester. PHO will not use a separate payment dispute to eliminate a patient’s lawful right to obtain records where such access is required by law.
33. RECORD RETENTION
PHO does not apply one universal retention period to every record because medical, financial, corporate, privacy, employment, pharmacy-related, laboratory-related, and other records may be subject to different legal or operational requirements. Retention may depend upon Florida professional-board requirements, the role of the records owner, AHCA requirements where applicable, federal law, contractual requirements, litigation holds, tax and accounting obligations, fraud-prevention requirements, or other legal considerations. PHO should maintain records for the period required by the applicable rule and securely dispose of records when retention is no longer required.
34. PRIVACY, SECURITY, AND BREACH RESPONSE
PHO maintains administrative, technical, and physical safeguards designed to protect information according to its sensitivity and the requirements applicable to that information. Such safeguards may include access controls, authentication, role-based permissions, secure clinical systems, training, physical protections, incident-response procedures, and appropriate vendor controls. No electronic system can be guaranteed to be completely immune from unauthorized access or technical failure. If PHO identifies a suspected privacy or security incident, PHO will evaluate the incident under HIPAA, Florida data-breach requirements, contractual obligations, and other applicable law and will provide notifications to individuals, regulators, or other parties when legally required.
35. FEES AND PAYMENT RESPONSIBILITY
Patients are responsible for PHO cash-pay charges associated with services they knowingly authorize. Charges may include consultations, assessments, procedures, treatment services, patient-specific medications, products, supplies, administrative services where lawful, recurring programs where applicable, and other disclosed services. PHO should communicate applicable pricing before payment where reasonably practicable. Outside charges imposed directly by Quest Diagnostics, Labcorp, an independent pharmacy, a shipping carrier, or another third-party entity are separate from PHO’s own cash-pay charges unless PHO expressly states otherwise.
All product purchases are subject to PHO’s No Return and No Refund Product Policy, and the cancellation or modification of an appointment, treatment plan, program, or future service does not by itself create a right to return or obtain a refund for a product already purchased or ordered.
36. CONSULTATION FEES
A consultation fee compensates PHO and the applicable healthcare professional for time and professional services associated with the consultation. Payment of the consultation fee does not guarantee a particular diagnosis, medication, prescription, treatment recommendation, product, or outcome. Once a consultation has been substantially performed, the consultation fee may be earned even if the provider ultimately concludes that the treatment originally requested by the patient is not clinically appropriate. Any cancellation or refund rights that apply before the consultation occurs are governed by PHO’s then-current disclosed financial and scheduling policy.
37. PAYMENT BEFORE PATIENT-SPECIFIC ORDERS
PHO requires payment before patient-specific medications, compounded preparations, supplements, medical products, treatment products, or other patient-specific items are ordered from a pharmacy, compounding facility, supplier, or other approved source. PHO does not maintain general standing inventory of unassigned patient medications or treatment products for anticipated future sale. Products are ordered specifically for the individual patient after the applicable assessment, provider review, treatment determination, patient authorization, and payment process have been completed. PHO is not required to finance, advance payment for, or place a patient-specific order before receiving the required payment. Once PHO has processed the patient’s payment and submitted or authorized the patient-specific product order in accordance with the treatment plan, the purchase is considered a final product transaction and is subject to PHO’s No Return and No Refund Product Policy described below.
38. THIRD-PARTY PAYMENT PROCESSING
PHO may use independent payment processors to process credit-card, debit-card, or other authorized electronic transactions. A payment processor may maintain its own privacy, security, fraud-prevention, banking, and transaction rules. PHO does not require ordinary operational systems to store complete card numbers, card security codes, banking passwords, or other restricted payment credentials when those credentials are intended to be handled by the authorized payment processor. Patients are responsible for providing valid payment information and for promptly notifying PHO if they reasonably believe a PHO charge is incorrect.
39. PRICING, ESTIMATES, AND CLERICAL ERRORS
PHO seeks to provide accurate pricing and service information, but an obvious typographical, clerical, mathematical, or publishing error does not require PHO to provide a service or product at a clearly erroneous price. When PHO discovers a material pricing error before a patient-specific order or service has been fulfilled, PHO should notify the patient and provide an opportunity to approve the corrected charge or decline the transaction. PHO should not use this provision as a pretext to retroactively increase a properly agreed patient-specific charge after the service has been performed without an independent legal or contractual basis.
Correction of a pricing or clerical error before fulfillment does not create a general product-return or refund right after the patient has knowingly approved the corrected transaction and the product purchase has been completed.
40. PHO FINAL SALE AND NO REFUND POLICY
All payments made to PharmXHealthOne for medications, products, consultations, assessments, treatments, procedures, services, programs, or other PHO offerings are subject to PHO’s Final Sale and No Refund Policy. PHO does not provide refunds, exchanges, store credits, account credits, or other reimbursement for medications or products that have been purchased or ordered, or for healthcare services, consultations, assessments, procedures, or treatments that have been partially or fully provided.
PHO maintains this policy because healthcare services and patient-specific products involve professional services, clinical judgment, staff time, facility resources, administrative processing, medical supplies, treatment materials, pharmacy or supplier charges, and other costs that are incurred when the service begins or the product is ordered. Once these resources have been committed or used for a particular patient, PHO cannot recover those costs simply because the patient later changes their mind, elects not to continue treatment, fails to complete the recommended treatment plan, changes providers, experiences a change in personal circumstances, or decides that the service or treatment is no longer desired.
For consultations, clinical assessments, diagnostic review, SECA mBCA assessments, treatment visits, procedures, injections, aesthetic services, body-contouring services, shockwave services, telehealth consultations, and other professional services, the fee compensates PHO and the applicable healthcare professional or staff for the work actually performed. Once any portion of the scheduled consultation, assessment, treatment, procedure, or other service has begun or has been provided, whether partially or fully, the amount paid for that service is non-refundable. A patient’s decision not to complete the remaining portion of a treatment, program, series, or plan does not create a right to a refund for work, professional time, services, materials, or resources already provided or committed.
The same principle applies when a healthcare professional determines during or after an evaluation that a requested treatment, medication, or procedure is not clinically appropriate. A consultation or assessment fee is payment for the professional evaluation itself and not a guarantee that the patient will receive the medication, treatment, diagnosis, or outcome the patient requested. Therefore, a patient is not entitled to a refund of an evaluation or consultation fee merely because the provider declines to prescribe a requested medication, recommends a different treatment, requires additional testing, refers the patient elsewhere, or determines that no PHO treatment is appropriate.
41. NO RETURNS OR REFUNDS FOR MEDICATIONS AND PRODUCTS
All medication and product purchases are final. PHO does not accept returns and does not issue refunds, exchanges, store credits, or account credits for prescription medications, compounded medications, injectable therapies, supplements, treatment products, medical supplies, wellness products, patient-specific products, or other items purchased through or ordered by PHO.
PHO’s medication and product policy exists for patient safety, regulatory compliance, product integrity, and the patient-specific nature of PHO’s ordering process. PHO does not maintain general standing inventory of unassigned patient medications for anticipated resale. Medications and treatment products are ordered specifically for the individual patient based upon the applicable assessment, laboratory information where required, health concerns, health goals, provider evaluation, individualized recommendation, and treatment plan. Once PHO submits the patient-specific order, pharmacy, supplier, preparation, compounding, packaging, fulfillment, and shipping costs may be incurred specifically for that patient and may not be recoverable.
Prescription medications, compounded products, injectable products, sterile products, and temperature-sensitive healthcare products also require appropriate handling, storage, temperature control, labeling, sterility, expiration management, and chain of custody. After a medication or product has been dispensed, shipped, delivered, released to the patient, or otherwise left the controlled custody of the dispensing pharmacy, supplier, or PHO, the product’s handling and storage conditions can no longer be independently verified for redistribution. PHO therefore does not place returned medications or patient-specific products back into inventory, resell them, or redistribute them to another patient.
This policy applies even if the patient changes their mind, chooses not to begin treatment, voluntarily stops treatment, changes treatment goals, changes providers, does not use all of the medication or product, fails to attend follow-up appointments, fails to complete recommended monitoring, or otherwise decides that the medication or product is no longer wanted.
42. PARTIALLY COMPLETED SERVICES AND TREATMENT PROGRAMS
When a patient purchases or begins a course of treatment, multi-visit service, package, program, procedure series, or other treatment arrangement, any services, professional time, supplies, materials, or treatment already provided are non-refundable. If the patient elects to discontinue the remaining portion of the treatment or program, PHO does not refund amounts attributable to services already rendered, work already performed, professional time already used, supplies already consumed, products already ordered, or other costs already incurred.
Where a package or treatment arrangement includes multiple components, PHO may allocate the amount paid among services, products, professional fees, pharmacy or supplier costs, and other components for accounting or dispute-review purposes. Such allocation does not create a right to a refund for any portion that has already been performed, supplied, ordered, consumed, or otherwise earned or incurred.
43. PATIENT CHANGE OF MIND OR DISCONTINUATION OF TREATMENT
A patient’s decision to change their mind after purchasing or beginning a PHO service does not create a refund right. This includes circumstances in which a patient later decides not to proceed with a treatment plan, chooses a different provider, relocates, experiences scheduling difficulty, changes financial priorities, does not achieve the result the patient hoped for, stops complying with the recommended treatment plan, or otherwise decides not to continue.
Healthcare outcomes cannot be guaranteed, and payment for healthcare services compensates PHO for professional services, treatment resources, clinical oversight, staff time, and other work performed rather than guaranteeing a particular result. Lack of the desired outcome does not by itself entitle a patient to a refund.
44. SAFETY, DISPENSING, OR FULFILLMENT CONCERNS
PHO’s No Refund Policy does not mean that a patient should use a medication or product that appears incorrect, damaged, contaminated, improperly labeled, temperature-compromised, expired, recalled, or otherwise unsafe. If a patient believes that a pharmacy dispensed the wrong medication, a supplier shipped the wrong product, a package was materially damaged, a temperature-sensitive shipment was compromised, or a product is subject to a recall or safety alert, the patient should promptly contact PHO and, when appropriate, the responsible pharmacy or supplier.
PHO will assist in evaluating the issue and determining the appropriate safety or fulfillment response. A correction, replacement, recall response, or other remedy provided by a responsible pharmacy, supplier, manufacturer, payment processor, or other third party because of an established error or legal obligation does not constitute a voluntary PHO refund and does not modify PHO’s general Final Sale and No Refund Policy.
45. LEGALLY REQUIRED EXCEPTIONS
PHO’s Final Sale and No Refund Policy applies to the fullest extent permitted by applicable law. Nothing in this policy is intended to eliminate a remedy that PHO is legally required to provide in the event of an unauthorized transaction, duplicate charge, proven billing error, failure by PHO to provide a service for which no portion of the service was performed, or another circumstance in which applicable law expressly requires a refund, reversal, correction, or other remedy.
46. WEBSITE ACCOUNTS, PORTALS, PASSWORDS, AND SECURITY
If PHO provides a patient, member, employee, provider, or other online account or portal, the authorized user is responsible for protecting the user’s own credentials and should not knowingly share login information with unauthorized persons. Users must not attempt to gain access to another person’s account, defeat authentication controls, bypass security restrictions, probe systems without authorization, install malicious code, interfere with system availability, scrape restricted information, steal credentials, impersonate another user, or use PHO systems for unlawful purposes. PHO may restrict or suspend access when reasonably necessary to protect patients, personnel, systems, information, or legitimate legal interests.
47. WEBSITE AVAILABILITY AND TECHNICAL LIMITATIONS
PHO seeks to maintain a functional and reasonably available website, but uninterrupted operation cannot be guaranteed. Temporary outages or degraded service may result from maintenance, internet failures, third-party platform outages, cybersecurity events, software errors, utility interruptions, weather, governmental action, or other circumstances outside PHO’s reasonable control. A website outage does not excuse PHO from professional duties that independently arise from an existing patient relationship, and patients should use an appropriate alternative contact method for non-emergency matters when a digital service is unavailable.
48. ACCESSIBILITY AND ACCOMMODATION
PHO seeks to provide reasonable access to its website, clinic, and services consistent with applicable disability-access requirements. Individuals who encounter difficulty accessing digital information or who require a reasonable accommodation should contact PHO so the request can be evaluated. Accommodation requests are considered based on the individual’s needs, the service involved, patient safety, applicable law, and available reasonable alternatives. PHO should maintain a separate Accessibility Statement on its website to provide practical contact information and procedures for accessibility concerns.
49. CLINIC CONDUCT, SAFETY, AND ACCOMPANYING PERSONS
Patients, visitors, staff, providers, contractors, and other individuals present at PHO facilities are expected to behave safely and respectfully. PHO may take appropriate action when a person engages in threatening conduct, violence, intimidation, harassment, stalking, intentional property damage, discriminatory abuse, fraudulent conduct, or behavior that materially interferes with patient care or facility safety. PHO may also establish reasonable rules concerning accompanying persons in consultation or treatment areas to protect patient privacy, infection control, clinical safety, and space limitations. Emergency or criminal matters may be referred to law enforcement or other appropriate authorities.
50. PHOTOGRAPHY, AUDIO RECORDING, AND VIDEO RECORDING IN THE CLINIC
To protect patient privacy, confidential conversations, workforce privacy, and clinical operations, photography, audio recording, or video recording in PHO treatment areas, consultation rooms, staff-only areas, or locations where another patient’s information could be captured should not occur without appropriate authorization. PHO may separately request written authorization when PHO wishes to photograph or record a patient for clinical documentation, educational use, testimonial use, advertising, or another purpose. Authorization for one purpose does not automatically authorize another use.
51. INFECTION CONTROL AND FACILITY SAFETY INSTRUCTIONS
Patients and visitors must comply with reasonable infection-control and safety instructions that apply to the clinic or a particular service. PHO may postpone non-emergency in-person care when a patient’s symptoms, exposure history, conduct, or failure to follow safety procedures creates an unreasonable risk to patients, staff, or providers. Nothing in this section restricts appropriate emergency referral or legally required accommodation.
52. COMMUNITY, CHURCH, AND PUBLIC OUTREACH EVENTS
PHO may participate in church, community, educational, wellness, or outreach activities to provide general information concerning PHO and available healthcare resources. Unless PHO specifically establishes a private clinical service at an event, such outreach should not be treated as an individualized medical consultation, diagnosis, prescription encounter, or substitute for PHO’s normal patient-care process. Individuals who wish to receive personal medical evaluation should be directed into PHO’s approved registration and clinical process.
53. PHO INTEREST CARDS
PHO may use physical or digital Interest Cards to collect limited information from people who request follow-up. An Interest Card may include contact information, general health or wellness interests, preferred contact method, requested next step, information about whether recent laboratory results are available, and optional consent to PHO Event & Community SMS Updates. The Interest Card is not intended to be a full medical-history form or substitute for the clinical record. Individuals should not use public Interest Cards to provide unnecessary detailed diagnoses, Social Security numbers, account passwords, complete payment-card information, or other information that does not belong in that public process.
54. COMMUNITY VOLUNTEERS AND PUBLIC REGISTRATION ASSISTANCE
A church member, community volunteer, or other helper may assist a participant with locating or completing a public PHO registration or Interest Card. Such assistance does not authorize that person to access Elation Health, patient records, QCommand Center, internal PHO portals, Airtable administration, private clinical communications, or other PHO backend systems. Volunteers are not authorized to diagnose conditions, interpret medical results, promise treatment, or provide medical advice on PHO’s behalf unless the person separately holds the required professional authority and is specifically acting within an authorized clinical role.
55. PHO EVENT & COMMUNITY SMS UPDATES
PHO may operate an optional recurring informational text-message program identified as PHO Event & Community SMS Updates. The program is intended for non-clinical communications concerning PHO event announcements, invitations, RSVP confirmations, event reminders, date and time reminders, location information, schedule or location changes, event cancellations, and related community-program notices. This program is not intended for patient-specific medical advice, laboratory results, prescription instructions, treatment instructions, healthcare-provider consultations, or patient appointment communications that belong within an approved patient or clinical communication process. It is also not intended to serve as authorization for promotional product advertising, treatment sales, discounts, coupons, or unrelated marketing campaigns.
56. SMS CONSENT
Participation in PHO Event & Community SMS Updates is voluntary and requires separate affirmative consent for recurring messages. Providing a mobile number, selecting “Text” as a preferred contact method, requesting general event information, filling out an Interest Card, becoming a PHO patient, or purchasing a PHO service does not by itself constitute consent to recurring Event & Community SMS messages. Consent is not a condition of receiving healthcare or purchasing a PHO service. PHO may retain evidence of consent including the mobile number, date and time, consent source, consent-language version, and opt-out status to demonstrate the basis for authorized messaging.
57. SMS MESSAGE FREQUENCY, CHARGES, STOP, AND HELP
Message frequency for PHO Event & Community SMS Updates varies according to event and community-program activity. Message and data rates may apply under the recipient’s wireless plan. A recipient may reply STOP to opt out and HELP for assistance. PHO should process valid opt-out requests promptly and should not continue recurring messages under that program after a valid opt-out is processed unless the person later provides new valid consent. Wireless-carrier delays, filtering, device settings, network outages, number reassignment, or other telecommunications conditions may affect delivery.
58. MOBILE INFORMATION AND SMS DATA USE
PHO does not sell or share SMS opt-in information or mobile telephone information with third parties or affiliates for their own independent marketing or promotional use. PHO may provide information reasonably necessary to an authorized communications vendor to deliver the PHO messaging program, maintain consent and suppression records, process STOP or HELP requests, prevent unauthorized messaging, or perform other necessary communications functions. Such access does not authorize the vendor to use PHO’s consent information for the vendor’s own unrelated advertising.
59. PATIENT-SPECIFIC CLINICAL AND APPOINTMENT COMMUNICATIONS
PHO’s patient-specific clinical and appointment communications are separate from the Event & Community SMS program. PHO may use Elation Health or another approved patient or administrative communication channel for scheduling, provider communication, clinical follow-up, laboratory matters, or other patient-specific information as appropriate. PHO personnel should use a communication method appropriate to the sensitivity of the information and should not place detailed medical content into the public Event & Community SMS stream.
60. EMAIL AND TELEPHONE COMMUNICATION
PHO may use email or telephone for legitimate administrative and healthcare-related purposes such as returning an inquiry, scheduling, registration, requested follow-up, payment administration, record requests, event coordination, and other appropriate communications. Ordinary email and telephone communication may have privacy limitations, and patients should avoid sending unnecessary detailed clinical information through a general public email account when a more secure method is available. Authorization for one type of communication does not automatically constitute authorization for unrelated marketing communications.
61. AUTOMATION AND ARTIFICIAL INTELLIGENCE
PHO may use software, automated workflows, analytics, or artificial-intelligence-assisted tools to support administrative and operational functions such as reporting, workflow routing, documentation support, status tracking, reminders, quality review, event administration, management analysis, and task assignment. Automation does not replace licensed healthcare-professional judgment. PHO does not authorize QCommand Center, Airtable, Twilio, website analytics, or another general operational platform to independently diagnose a patient, prescribe medication, determine treatment eligibility without provider involvement, or make a final autonomous clinical treatment decision.
62. NO GUARANTEE OF HEALTHCARE RESULTS
Healthcare outcomes vary substantially among individuals. PHO does not guarantee that a patient will receive a particular diagnosis, qualify for a requested medication, lose a particular amount of weight, achieve a specific hormone level, obtain a particular laboratory result, experience improvement in a symptom, achieve a specific aesthetic or body-composition result, require treatment for a particular duration, or obtain any other guaranteed medical or wellness outcome. Testimonials, examples, before-and-after materials, educational statements, and descriptions of possible benefits are not guarantees that another person will experience the same result.
63. TREATMENT RISKS, LIMITATIONS, AND INFORMED CONSENT
Healthcare treatments may involve risks, side effects, complications, contraindications, limitations, and alternatives, and the nature of those issues differs by treatment and patient. PHO may require treatment-specific informed consent before providing a medication, procedure, telehealth service, aesthetic service, injection, compounded therapy, or other treatment. These general Terms do not replace treatment-specific consent or the provider’s responsibility to discuss material information appropriate to the treatment. Patients are encouraged to ask questions before agreeing to a treatment and should promptly report significant adverse effects or unexpected reactions.
64. PATIENT RESPONSIBILITY FOR FOLLOW-UP AND SAFETY
Patients are expected to participate reasonably in their healthcare and comply with medically appropriate follow-up instructions. Depending on the treatment, this may include completing recommended laboratory testing, attending follow-up appointments, reporting adverse reactions, informing PHO about material changes in health, notifying PHO of medication changes, following storage and administration instructions, following pre-procedure and post-procedure directions, and seeking emergency care when instructed or when symptoms warrant emergency evaluation. A provider may pause or discontinue treatment when necessary safety monitoring has not been completed.
65. DISCONTINUATION OR REFUSAL OF NON-EMERGENCY SERVICES
PHO or a treating provider may decline, pause, or discontinue non-emergency services when legally and professionally permissible. Circumstances may include treatment becoming inappropriate, inability to obtain information necessary for safe care, provider licensure or jurisdictional limitations, safety concerns, fraudulent behavior, threatening or abusive conduct, repeated failure to comply with clinically necessary monitoring, inability to maintain an appropriate professional relationship, or another lawful reason. Where professional duties require notice, transition planning, record access, referral, or other continuity measures, the treating healthcare professional must comply with those requirements.
66. INTELLECTUAL PROPERTY
PHO’s original trademarks, logos, branding, website text, graphics, photographs, videos, educational materials, documents, and other proprietary content are protected by applicable intellectual-property law. Public website content may be viewed for lawful personal informational purposes, but users may not falsely represent PHO materials as their own, commercially exploit PHO content without authorization, remove applicable rights notices, or reproduce or distribute protected material in violation of applicable copyright, trademark, or other intellectual-property law.
67. USER SUBMISSIONS AND PROHIBITED WEBSITE USE
Users may not use PHO’s website, portals, forms, or systems to engage in fraud, impersonate another person, knowingly submit materially false information, transmit malicious code, attempt unauthorized system access, harass or threaten another person, interfere with PHO’s operations, unlawfully obtain confidential information, infringe intellectual-property rights, or engage in another unlawful activity. PHO may restrict access or take appropriate technical or legal measures when reasonably necessary to protect patients, personnel, systems, property, or legal interests.
68. THIRD-PARTY WEBSITES AND SERVICES
PHO’s website or communications may provide links or access points to independent services such as Elation Health, Quest Diagnostics, Labcorp, pharmacies, payment processors, government agencies, social-media platforms, or educational resources. Once a user enters an independent third-party service, that entity’s privacy practices, terms, billing policies, security procedures, and other rules may apply. A link does not mean that PHO controls or guarantees every aspect of the third party’s operations, and users should review the third party’s applicable terms and notices.
69. LIMITATIONS RELATING TO GENERAL WEBSITE USE
To the extent permitted by applicable law, PHO is not responsible for indirect or consequential losses arising solely from ordinary reliance on general non-clinical website information or temporary inability to access a public website feature where PHO has not breached an applicable legal duty. Nothing in this section waives a patient’s legally protected rights, excuses professional negligence, excuses gross negligence or intentional misconduct, eliminates healthcare duties imposed by law, or limits a remedy that cannot legally be waived.
70. NO BLANKET WAIVER OF MEDICAL NEGLIGENCE RIGHTS
These general Terms do not require a person to waive professional-negligence rights merely because the person visited the PHO website, completed an Interest Card, attended a PHO event, or used another public PHO service. Any informed-consent, liability, or dispute-resolution agreement affecting professional healthcare rights must comply with applicable Florida law and should be separately reviewed and presented where appropriate. PHO will not use these website Terms as a blanket substitute for the legal procedures governing healthcare liability.
71. DISPUTES AND FLORIDA MEDICAL-NEGLIGENCE PROCEDURES
Ordinary business disputes that are not governed by a specialized healthcare statutory process should, where reasonable, first be addressed through good-faith communication between the affected parties. Medical-negligence matters remain subject to the applicable Florida statutory framework and are not converted into ordinary website disputes merely because a patient used PHO’s website. These Terms do not state that every PHO patient has automatically agreed to binding medical-malpractice arbitration or waived a jury trial by using the website. Any separate arbitration agreement affecting healthcare claims should be specifically reviewed by Florida healthcare counsel before PHO adopts it.
72. GOVERNMENTAL AND REGULATORY COMMUNICATIONS
Nothing in these Terms prevents a patient, employee, provider, contractor, consumer, or other person from communicating with AHCA, the Florida Department of Health, a Florida professional licensing board, HHS or its Office for Civil Rights, FDA, FTC, FCC, CMS, law enforcement, another governmental body, or another regulator; filing a legally protected complaint; reporting suspected misconduct; or participating in a governmental investigation. PHO permission is not required before an individual makes a communication protected by law.
73. APPLICABLE LOCAL REQUIREMENTS
PHO will comply with applicable Palm Beach County and City of Boynton Beach requirements governing PHO’s physical location and business operations, including business licensing or tax-registration requirements, zoning or permitted-use requirements, occupancy, fire and life-safety requirements, building requirements, and other local requirements to the extent each applies to PHO’s facility and operations. These Terms do not state that PHO holds a specific local permit unless that permit has been separately verified.
74. GOVERNING LAW
These Terms are governed by applicable federal law and the laws of the State of Florida. Where a specific healthcare, privacy, professional, pharmacy, laboratory, consumer-protection, electronic-transaction, or other matter is governed by a specialized statutory or regulatory process, that specialized process controls to the extent legally applicable.
75. CHANGES TO PHO SERVICES
PHO may modify, replace, suspend, or discontinue a non-contracted service, technology, program, vendor relationship, product category, or website feature when reasonably necessary. Clinical services may also change because of new medical evidence, changes in provider judgment, safety concerns, pharmacy or supplier availability, medication shortages, recalls, regulatory changes, changes in law, or other circumstances. PHO will address any existing patient-care obligations according to applicable professional standards, agreements, and law rather than relying solely on this section.
76. CHANGES TO THESE TERMS
PHO may revise these Terms when reasonably necessary because of changes in law, regulation, services, technology, vendors, treatment offerings, payment practices, communications, privacy requirements, security practices, or business operations. The Last Updated date at the top of the page identifies the current published version. PHO will not rely solely on website publication of amended Terms when applicable law requires separate notice, affirmative consent, renewed authorization, or execution of a new agreement.
77. NO WAIVER
PHO’s failure to enforce a provision of these Terms on one occasion does not automatically waive PHO’s ability to enforce that lawful provision in another circumstance. This section does not convert an invalid, unlawful, or unenforceable provision into an enforceable one.
78. SEVERABILITY
If a court or other competent authority determines that a provision of these Terms is invalid, unlawful, or unenforceable, that determination should not invalidate unrelated provisions that can lawfully continue to operate. The affected provision should be interpreted or limited only to the extent reasonably necessary to comply with applicable law.
79. ENTIRE GENERAL TERMS AND RELATIONSHIP TO OTHER PHO DOCUMENTS
These Terms constitute PHO’s general Terms and Conditions for the subjects expressly covered here. They do not replace patient-specific informed consent, treatment agreements, financial responsibility agreements, recurring-payment authorizations, Good Faith Estimates, telehealth consent, privacy notices, prescription instructions, pharmacy disclosures, laboratory documents, or service-specific policies. When a valid service-specific document governs a particular issue, that document and applicable law control that particular issue.
80. CONTACT INFORMATION
Questions concerning these Terms and Conditions may be directed to PharmXHealthOne, PHARM X UNIVERSAL, LLC d/b/a PHARMXHEALTHONE, 2828 South Seacrest Boulevard, Suite 216, Boynton Beach, Florida 33435. PHO may also be contacted by telephone at 561-778-8121 or by email at health@pharmxhealthone.com. Sensitive medical information should not be sent through a general email address when a more appropriate secure clinical communication process is available.
81. RELATED PHO LEGAL NOTICES AND PATIENT DOCUMENTS
These Terms should be read together with PHO’s Legal Notice, Privacy Policy & Cookie Notice, HIPAA Notice of Privacy Practices, Good Faith Estimate / No Surprises Act Notice, Telehealth Consent, Consent to Treatment, Accessibility Statement, Cookie Preferences, applicable financial policies, and treatment-specific informed-consent documents. PHO should only place a clickable link on this page when the corresponding public notice or document actually exists in its current approved form.
82. PHO EVENT & COMMUNITY SMS UPDATES — TERMS AND CONDITIONS
Program Name: PHO Event & Community SMS Updates
Program Operator: PHARM X UNIVERSAL, LLC, doing business as PharmXHealthOne.
Program Description
PharmXHealthOne offers an optional recurring text-message program providing nonclinical information about community health events, event registration confirmations, RSVP reminders, event dates and locations, scheduling or location changes, cancellations, and related community-program notices.
This program does not provide medical advice, diagnoses, laboratory results, prescription information, treatment instructions, or patient-specific clinical communications. The program is not intended for unrelated product advertisements or promotional sales messages.
Enrollment and Consent
Individuals may enroll by completing the PHO Interest Card at https://www.pharmxhealthone.com/interestcard and voluntarily selecting the separate SMS consent checkbox.
The checkbox is optional and unchecked by default. Providing a telephone number, selecting Text as a preferred contact method, or submitting an Interest Card without selecting the SMS consent checkbox does not constitute enrollment. Consent is voluntary and is not required to receive healthcare services, register for a community event, or purchase any PHO service.
Message Frequency
Message frequency varies depending on community events, event registration activity, and relevant scheduling updates.
Message and Data Charges
Message and data rates may apply. Charges depend on the recipient's mobile service plan and wireless carrier.
How to Stop Messages
Reply STOP to any PHO Event & Community SMS message to unsubscribe. Once the opt-out is processed, recurring messages under this program will stop unless the individual subsequently provides new valid consent.
How to Get Help
Reply HELP for assistance. Participants may also contact PharmXHealthOne at 561-778-8121 or visit https://www.pharmxhealthone.com.
Delivery and Carrier Information
Wireless carriers are not liable for delayed or undelivered messages. Message delivery may be affected by network availability, carrier filtering, service interruptions, telephone-number changes, or device settings.
Privacy and Information Sharing
PharmXHealthOne does not sell or share SMS opt-in information, mobile numbers, or SMS consent data with third parties or affiliates for their independent marketing or promotional purposes.
For additional details about how personal information and SMS consent records are collected, used, and protected, review our Privacy Policy:
https://www.pharmxhealthone.com/legalnotice-privacy-cookienotice
Program Contact Information
PharmXHealthOne
PHARM X UNIVERSAL, LLC d/b/a PharmXHealthOne
2828 South Seacrest Boulevard, Suite 216
Boynton Beach, FL 33435
Telephone: 561-778-8121
Website: https://www.pharmxhealthone.com
These SMS Terms supplement the general PharmXHealthOne Terms and Conditions and do not replace the separate requirements applicable to patient-specific clinical communications.
FINAL WEBSITE STATEMENT
These Terms and Conditions should be read together with PHO’s applicable privacy notices, HIPAA notices, informed-consent documents, financial policies, Good Faith Estimates, telehealth documentation, laboratory and pharmacy disclosures, treatment-specific documents, and all federal, Florida, and local requirements applicable to the particular PHO service, healthcare professional, transaction, communication, or patient relationship.
bottom of page